MedPath

Effects of Vitamin D Supplementation on Immune Function in Infants

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Interventions
Other: vitamin D
Registration Number
NCT04461665
Lead Sponsor
Shih Chien University
Brief Summary

Current study shows that vitamin D deficiency might affect human's immune function. Although breast milk is the best food of infants, however the vitamin D content in breast milk is low. Thus, breastfeeding infants are at high risk of vitamin D deficiency.Children's development and health are always the most important issues for parents. However, high prevalence of allergy in infants in Taiwan were not only with environmental factor which may also relate to their nutritional status. The aim of this study was to enroll breastfeeding infant at age of 4 month, and provide vitamin D supplement 10 μg daily until 6 month, to discuss the effects of vitamin D supplementation on immune function in infants.

Detailed Description

Study plan to enroll breastfeeding infant at age of 4 month, and provide vitamin D (vitD) supplement 10 μg daily until 6 month. we also enroll 6 month-old infant as control group.

All infants collected 5 ml artery blood and measured vitD nutritional status and immune function. Blood analysis contain complete blood count (CBC), differential count (DC), serum calcium, serum Parathyroid hormone (PTH), serum 25(OH)D3, serum total immunoglobulinE (IgE) and cell phagocytosis.

Peripheral blood mononuclear cell (PBMC) in blood was separated and cultured with complete medium contain 10% fetal bovine serum (CM10), or with different mitogens, include lipopolysaccharide (LPS), phorbol 12-myristate 13-acetate and ionomycin (PI) and house dust mite extract (HDM). PBMC are incubated at 37 ℃, 5% CO2 for 48 hours, and determined the expression of B cell with IgE receptor CD21 and CD23 and T regulatory cell with transcription factor Foxp3 by flow cytometry. All data were analyzed with SPSS 20.0. Infant sex and feeding type were analyzed by chi-square analysis. Difference between vitD supplement group and control group were analyzed by student's t test. Relationship between 25(OH)D3 and Calcium or PTH were analyzed by pearson correlation analysis. There was a significant difference when p-value was less than 0.05.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Breastfeeding healthy infants
Exclusion Criteria
  • heart disease
  • liver disease
  • lung disease
  • Intestinal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VitD supplementvitamin DEnroll 4 months old breast feeding infant, and provide 10 μg vitamin D daily for 2 months.
Primary Outcome Measures
NameTimeMethod
Vitamin D nutritional status of infants-2Infants at 4 and 6 months old

PTH (pg/mL) in both groups

The anthropometric of infants from 4 months old to 6 months old-2Infants at 4 and 6 months old

Weight percentile (%) in both groups

Characteristic of infants-5Infants at 4 months old

Birth head circumference (cm) in baseline

Characteristic of infants-6Infants at 4 months old

Exposed to the sun (min/day) in baseline

Characteristic of infants-1Infants at 4 months old

Gender in baseline

Characteristic of infants-4Infants at 4 months old

Birth weight (kg) in baseline

Characteristic of infants-8Infants at 4 months old

Mixed-fed n (%) in baseline

Vitamin D nutritional status of infants-1Infants at 4 and 6 months old

Ca (mg/dL) in both groups

Characteristic of infants-2Infants at 4 months old

Gestational week (week) in baseline

Characteristic of infants-3Infants at 4 months old

Birth length (cm) in baseline

Vitamin D nutritional status of infants-3Infants at 4 and 6 months old

25(OH)D3 (ng/mL) in both groups

Characteristic of infants-7Infants at 4 months old

Exclusive breast-fed n (%) in baseline

The anthropometric of infants from 4 months old to 6 months old-1Infants at 4 and 6 months old

Length percentile (%) in both groups

Secondary Outcome Measures
NameTimeMethod
Serum immunoglobulin E level of infantsInfants at 6 months old

Concentration of IgE (ng/ml) in both groups

Cell markers expression of B cellsInfants at 6 months old

D21 and CD23 expression (%) in both groups

Cytokine levels in supernatant of lymphocyte by LPS induction-1Lymphocyte isolation from Infants at 6 months old

Concentration of IL-6 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by PI induction-1Lymphocyte isolation from Infants at 6 months old

Concentration of IL-4 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by PI induction-4Lymphocyte isolation from Infants at 6 months old

Concentration of TGF-β (pg/ml) in both groups

Cell markers expression of T cellsInfants at 6 months old

Foxp3 expression (%) in both groups

Cytokine levels in supernatant of lymphocyte by CM-10 induction-5Lymphocyte isolation from Infants at 6 months old

Concentration of TGF-β (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by HDM induction-3Lymphocyte isolation from Infants at 6 months old

Concentration of IL-13 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by HDM induction-4Lymphocyte isolation from Infants at 6 months old

Concentration of IL-10 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by CM-10 induction-1Lymphocyte isolation from Infants at 6 months old

Concentration of IL-6 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by CM-10 induction-2Lymphocyte isolation from Infants at 6 months old

Concentration of IL-4 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by LPS induction-2Lymphocyte isolation from Infants at 6 months old

Concentration of TNF-α (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by PI induction-2Lymphocyte isolation from Infants at 6 months old

Concentration of IL-13 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by PI induction-3Lymphocyte isolation from Infants at 6 months old

Concentration of IL-10 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by HDM induction-1Lymphocyte isolation from Infants at 6 months old

Concentration of IFN-γ (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by HDM induction-5Lymphocyte isolation from Infants at 6 months old

Concentration of TGF-β (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by CM-10 induction-3Lymphocyte isolation from Infants at 6 months old

Concentration of IL-13 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by CM-10 induction-4Lymphocyte isolation from Infants at 6 months old

Concentration of IL-10 (pg/ml) in both groups

Cytokine levels in supernatant of lymphocyte by HDM induction-2Lymphocyte isolation from Infants at 6 months old

Concentration of IL-4 (pg/ml) in both groups

Trial Locations

Locations (1)

Shih Chien University

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath